TAK-700
Orteronel (TAK-700) is a highly selective 17,20-lyase inhibitor with an IC50 of 38 nM, showing >1000-fold selectivity over related CYPs. It has been investigated in clinical research, including Phase 3 trials, for conditions like prostate cancer, where it targets androgen biosynthesis in both in vitro and in vivo models.
Product Specifications
CAS Number
426219-18-3
Product Name Alternative
Orteronel, 17,20-lyase (Human), 17,20-lyase (Rat), (S/R) -Orteronel, TAK 700, TAK700, TAK-700
Field of Research
Epigenetics & Chromatin, Metabolism Research
Purity
97.26% (May vary between batches)
Solubility
DMSO:57 mg/mL (185.46 mM) ; H2O:< 1 mg/mL (insoluble or slightly soluble) ;10% DMSO+40% PEG300+5% Tween 80+45% Saline:1 mg/mL (3.25 mM) ; Ethanol:8 mg/mL (26.03 mM)
Smiles
OC1 (C=2N (CC1) C=NC2) C3=CC4=C (C=C3) C=C (C (NC) =O) C=C4
Molecular Formula
C18H17N3O2
Molecular Weight
307.35
Storage Conditions
-20°C
Notes
For research use only.
Available Sizes
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
OR1066669-01 100 mg
N, N-Bis (4-bromophenyl) -2,4,6-trimethylaniline
Sign In for Pricing
View Details OR1066669-02 250 mg
N, N-Bis (4-bromophenyl) -2,4,6-trimethylaniline
Sign In for Pricing
View Details